Ineffective therapy, underpowered studies, or merely too little, too late? Risk factors and impact of maternal corticosteroid treatment on outcome in antibody-associated fetal heart block

Editorial

Jodi I Pike et al. Circulation. 2011.

. 2011 Nov 1;124(18):1905-7.

doi: 10.1161/CIRCULATIONAHA.111.061267.

No abstract available

Comment on

Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.
Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, Friedman D, Buyon JP. Izmirly PM, et al. Circulation. 2011 Nov 1;124(18):1927-35. doi: 10.1161/CIRCULATIONAHA.111.033894. Epub 2011 Oct 3. Circulation. 2011. PMID: 21969015 Free PMC article.
Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients.
Eliasson H, Sonesson SE, Sharland G, Granath F, Simpson JM, Carvalho JS, Jicinska H, Tomek V, Dangel J, Zielinsky P, Respondek-Liberska M, Freund MW, Mellander M, Bartrons J, Gardiner HM; Fetal Working Group of the European Association of Pediatric Cardiology. Eliasson H, et al. Circulation. 2011 Nov 1;124(18):1919-26. doi: 10.1161/CIRCULATIONAHA.111.041970. Epub 2011 Oct 10. Circulation. 2011. PMID: 21986286